Literature DB >> 7626691

Markers for vulnerability in acute porphyria. A hypothesis paper.

S Thunell1, C Andersson, B Carlmark, Y Floderus, S O Grönqvist, P Harper, A Henrichson, U Lindh.   

Abstract

Previously symptomatic and permanently asymptomatic carriers of a gene mutation for acute intermittent porphyria as well as matched controls were screened with regard to a series of variables of possible relevance to the development of porphyric symptoms. The basis for the study was a concept of acute porphyria as a condition of a permanent system overload of oxidative stress, with long term effects on hepatic and renal tissue, and with instances of periodic overload of free radicals giving rise to acute neurologic involvement. Leukocyte concentrations of manganese, calcium, iron and zinc, as well as erythrocyte calcium differed between the groups, acute intermittent porphyria gene carriers, irrespective of previous porphyric illness, showing significantly higher levels than the controls. Manganese was found to be the most discriminative component of all the 78 variables investigated, accounting for about 98 per cent of the variance between the groups. An increment, by a factor of four, in cellular manganese is suggestive of an increase, in acute intermittent porphyria, of a manganese associated enzyme, e.g. glutamine synthetase, pyruvate carboxylase or mitochondrial superoxide dismutase. The best fit into the model considered is provided by a theory focused on superoxide dismutase, induced in response to superoxide anion radical produced from aminolaevulinic acid. In porphyria gene carriers seemingly resistant to porphyric manifestations, an increase in potentially prooxidant cellular iron is matched by a proportional increment in manganese, i.e. presumably by a corresponding mitochondrial superoxide dismutase induction. This mechanism is not operative in porphyric individuals prone to development of neuropsychiatric symptoms. In acute intermittent porphyria with a history of porphyric illness there is a positive correlation between erythrocyte manganese and serum folate and a negative correlation between leukocyte ferrochelatase activity and serum cobalamin concentration. This may mirror a role of the cobalamin-folate system in the acute porphyric process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626691     DOI: 10.1515/cclm.1995.33.4.179

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  8 in total

Review 1.  Erythropoietic and hepatic porphyrias.

Authors:  U Gross; G F Hoffmann; M O Doss
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

Review 2.  The little imitator--porphyria: a neuropsychiatric disorder.

Authors:  H L Crimlisk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

3.  High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria.

Authors:  Eliane Sardh; Staffan Wahlin; Mikael Björnstedt; Pauline Harper; Dan E H Andersson
Journal:  J Inherit Metab Dis       Date:  2013-01-23       Impact factor: 4.982

4.  Biochemical characterization of porphobilinogen deaminase-deficient mice during phenobarbital induction of heme synthesis and the effect of enzyme replacement.

Authors:  Annika Johansson; Christer Möller; Jens Fogh; Pauline Harper
Journal:  Mol Med       Date:  2003 Sep-Dec       Impact factor: 6.354

5.  Renal failure affects the enzymatic activities of the three first steps in hepatic heme biosynthesis in the acute intermittent porphyria mouse.

Authors:  Carmen Unzu; Ana Sampedro; Eliane Sardh; Itsaso Mauleón; Rafael Enríquez de Salamanca; Jesús Prieto; Eduardo Salido; Pauline Harper; Antonio Fontanellas
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

6.  Haem Biosynthesis and Antioxidant Enzymes in Circulating Cells of Acute Intermittent Porphyria Patients.

Authors:  Miguel D Ferrer; Antonia Mestre-Alfaro; Magdalena Martínez-Tomé; Lucrecia Carrera-Quintanar; Xavier Capó; Antonia M Jiménez-Monreal; Luis García-Diz; Enrique Roche; María A Murcia; Josep A Tur; Antoni Pons
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

Review 7.  Nutrients and Porphyria: An Intriguing Crosstalk.

Authors:  Elena Di Pierro; Francesca Granata
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

Review 8.  Role of Vitamin C in Skin Diseases.

Authors:  Kaiqin Wang; Hui Jiang; Wenshuang Li; Mingyue Qiang; Tianxiang Dong; Hongbin Li
Journal:  Front Physiol       Date:  2018-07-04       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.